500 tumor mutations are tested in colon cancer. This includes KRAS, NRAS, BRAF and Microsatellite Instability (MSI) markers. BRAF inhibitors (Sorafenib, Nexavar and Vemurafenib) are available to treat patients with colon cancer. BRAF mutations in colorectal cancer.
Home » Expert Centers » Colorectal Cancer » Colon cancer tumor markers. Precision medicine diagnosis. 3